Roche said today it will launch a CHF 100 million ($100.1 million) global network of 21 academic centers focused on cancer immunotherapy R&D.
The new Centers of Research Excellence (imCORE™) Network aims to advance promising new immuno-oncology treatments by quickly carrying out preclinical and clinical research, as well as aggregating and sharing data.